Quidel Corporation is a leading manufacturer of diagnostic solutions at the point of care delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the medical device industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Under trusted brand names Sofia®, Solana®, Lyra®, Triage® and QuickVue®, Quidel’s comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel’s mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our families, our communities and the world.
To avoid fraudulent job listings, search and apply for Quidel career opportunities at https://quidel.link/JobOpportunities.
|
|
|
501-1,000 employees
View all Quidel employees
|
|
Medical Devices
|
|
9975 Summers Ridge, San Diego, CA 92121, US
|
|
1979
|
|
Direct Fluorescent Antibodies (Dfa), Fluorescent Immunoassay Products, Lateral Flow Infectious Disease And Reproductive Health Diagnostics, Molecular Diagnostic Products
|
Brian Smith is the CEO of Quidel. To contact Brian Smith email at [email protected] or [email protected]. Or you may call 610-314-5751 or 4845532441
The decision makers in Quidel are Brian Smith, Dave Sieber, Gaston Garcia, etc. Click to Find Quidel decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.